By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


IsoRay, Inc. 

350 Hills Street
Suite 106
Richland  Washington  99354  U.S.A.
Phone: 509-375-1202 Fax:


Medical Device

Company News
IsoRay, Inc. (ISR)'s Cesium-131 Isotope Produces Excellent Results In Treating Metastatic Brain Cancer As Published In The Journal Of Neurosurgery 8/6/2014 10:49:27 AM
IsoRay, Inc. (ISR) Makes First Cesium-131 Delivery For Treatment Of An Inoperable Brain Cancer Afflicting A Young Child In Peru 7/15/2014 11:57:10 AM
IsoRay, Inc. (ISR) Announces Its Addition To The Russell Microcap Index 7/1/2014 10:18:38 AM
IsoRay, Inc. (ISR) Announces World's First Liquid Cesium-131 (Cesitrex®) Treatment For Metastatic Brain Cancer Utilizing The Gliasite® Radiation Therapy Balloon Catheter System 6/25/2014 11:23:48 AM
IsoRay, Inc. (ISR) Announces New Russian And Peruvian International Distributor Agreements For The Sale Of IsoRay's Full Line Of Products 6/20/2014 10:52:44 AM
IsoRay, Inc. (ISR) Reports Third Quarter Results 5/19/2014 9:19:25 AM
IsoRay, Inc. (ISR)'s Liquid Cesium-131 (Cesitrex®) Recieves Final Regulatory Approval for Use in GliaSite® Brain Cancer Treatment System 5/12/2014 10:04:11 AM
IsoRay, Inc. (ISR) Announces World's First Human Prostate Implant Utilizing Cesium-131 Seeds and C4 Imaging's Positive Signal MRI Markers 4/8/2014 10:07:46 AM
IsoRay, Inc. (ISR) Announces Five Presentations At American Brachytherapy Society Convention Reporting On The Ongoing Success Of Cesium-131 In Fighting Cancer 4/2/2014 10:17:27 AM
IsoRay, Inc. (ISR) Closes $14,675,180 Registered Direct Offering 3/28/2014 8:13:29 AM